Warning Letter — Shouly Import Corp.
The FDA issued a Warning Letter to Shouly Import Corp. on June 26, 2026, following an evaluation by the Office of Inspections and Investigations.
This action affects Shouly Import Corp. and potentially its regulatory, quality, and import operations departments.
A Warning Letter indicates that the FDA has identified significant violations of regulatory requirements. For an import corporation, this likely signals deficiencies in compliance regarding imported products, which could lead to import alerts, product detentions, or further enforcement actions if the underlying issues are not remediated.
Regulatory and QA teams should conduct a thorough audit of import documentation and supplier verification programs to ensure alignment with FDA requirements. Firms receiving such letters should prepare a formal response addressing the specific observations within the mandated timeframe.
FDA Warning Letter issued to: Shouly Import Corp.. 06/26/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/shouly-import-corp-731741-06262026
Open in openFDA / FDA.gov